JO
Joshua Daniel Ooi

Highly Cited

137
Works
4,153
Citations
37
H-Index
Search Authors
Author Statistics
External Links
OpenAlex Profile ORCID Profile

Joshua Daniel Ooi

Also known as: J Ooi, J. Ooi, J.D. Ooi, JOSHUA D OOI, Joshua Daniel Ooi

137

Total Works

4,153

Citations

37

H-Index

61

i10-Index

Citation & Works Trend by Year
21 years active
Top Research Topics
Systemic Lupus Erythematosus Research (79) Vasculitis and related conditions (71) Renal Diseases and Glomerulopathies (55) T-cell and B-cell Immunology (41) vaccines and immunoinformatics approaches (13)
Recent Publications
15 shown
Year Publication Title Citations Action
2026 Tregs transduced with a Ro60-reactive TCR have increased immunosuppressive functions in Sjögren’s disease iScience 0
2026 First application of dPCR for Lentiviral Vector Copy Number and Post-infusion monitoring of TCR-Engineered Regulatory T Cells Research Square 0
2026 The future of TCR-Treg therapies is renewables Autoimmunity Reviews 1
2026 ID #528 Immunotherapeutic Target Discovery in Paediatric Diffuse Midline Glioma: From H3K27M Neoantigens to Dark Antigens Neuro-Oncology Pediatrics 0
2026 Assessment of pH-Responsive Ionisable Lipid Nanoparticles as Cisplatin Delivery Vehicles for Treating Cisplatin-Resistant Ovarian Cancer Pharmaceutics 1
2026 REWRITING CELL THERAPY MANUFACTURING: A ONE-STEP WHOLE BLOOD PROCESSING FOR SCALABLE TREG THERAPIES Cytotherapy 0
2026 TCR recognition of peptide–HLA class II complexes in autoimmunity: Structural insights for therapeutic targeting Journal of Autoimmunity 1
2026 Are All Cells Created Equal? Novel Cell-Based Regenerative Therapies in Inflammatory Bowel Disease International Journal of Molecular Sciences 0
2026 Hybrid CARs: rewiring macrophage signaling for targeted therapy in acute and chronic kidney inflammation Kidney International 0
2026 Characteristics of T-Cells Expressing IL-37 and Its Receptors in Inflammatory Bowel Disease International Journal of Molecular Sciences 2
2026 Editorial: Community series: systemic vasculitis: advances in pathogenesis and therapies, volume II Frontiers in Immunology 0
2025 The Potential of β-Synuclein-Specific Regulatory T Cell Therapy as a Treatment for Progressive Multiple Sclerosis International Journal of Molecular Sciences 2
2025 Risk factors for severe infections during induction therapy of patients with microscopic polyangiitis Clinical and Experimental Rheumatology 0
2025 Regulatory T cell therapy for myeloperoxidase-specific anti-neutrophil cytoplasmic antibody associated vasculitis Frontiers in Immunology 2
2025 Low dose IL-2 administration prevents but fails to treat experimental autoimmune anti-myeloperoxidase glomerulonephritis Nephrology Dialysis Transplantation 0

Data source: OpenAlex API